Linezolid Krka

Linezolid, the active ingredient in Linezolid Krka, is an oxazolidinone presented as an oral formulation for systemic use. It treats infections caused by susceptible Gram‑positive bacteria, including methicillin‑resistant Staphylococcus aureus (MRSA) and community‑acquired pneumonia, in adult patients. The drug is supplied in tablet form and is intended for prescription‑only administration under medical supervision. It is indicated for severe infections where alternative agents are limited, offering a valuable option in antimicrobial stewardship programs.

GNH USA supplies Linezolid Krka as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with reliable logistics and quality assurance.

Linezolid is an oxazolidinone antibiotic used to treat serious infections caused by Gram‑positive bacteria. - Methicillin‑resistant Staphylococcus aureus (MRSA) infections: effective therapy for skin, soft‑tissue and bloodstream infections caused by MRSA. - Community‑acquired pneumonia: provides coverage against typical and atypical pathogens in adult patients. - Other susceptible Gram‑positive infections: treats skin and soft‑tissue infections, diabetic foot infections, and bacteremia caused by susceptible strains.

Linezolid may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea - Diarrhea - Headache - Metallic taste - Vomiting - Rash

Serious or Rare Side Effects: - Thrombocytopenia - Peripheral neuropathy - Serotonin syndrome - Lactic acidosis - Optic neuropathy - Severe hypotension

When prescribing linezolid, clinicians should consider several safety precautions to minimize risks. - Renal impairment: assess renal function and monitor for accumulation. - Hepatic impairment: evaluate liver enzymes and adjust therapy if needed. - Concomitant serotonergic agents: avoid due to risk of serotonin syndrome. - Myelosuppression: perform regular complete blood count monitoring. - Pregnancy and lactation: use only if potential benefits outweigh risks. - Store at below 25°C: keep in original packaging, protect from moisture.

Linezolid interacts with several medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - SSRIs, SNRIs and other serotonergic drugs: risk of serotonin syndrome. - Monoamine oxidase inhibitors (MAOIs): may precipitate serotonin syndrome.

Moderate Interactions (Monitor Closely): - Rifampin: induces metabolism, lowering linezolid plasma levels. - Warfarin: may increase INR, requiring closer coagulation monitoring. - Erythromycin or other macrolides: can raise linezolid concentrations, increasing toxicity risk.